Pharmaceutical compositions with tetrabenazine
作者： Okponanabofa Eradiri , Andrew John Duffield , Steven E. Frisbee , John Ck Lai , Graham Jackson
DOI:
关键词:
摘要: The present invention provides for a pharmaceutical composition that includes tetrabenazine and release-retarding agent; method of treating hyperkinetic movement disorder (e.g., Huntington's disease, chorea associated with hemiballismus, senile chorea, tic disorders, tardive dyskinesia, myoclonus, dystonia and/or Tourette's syndrome). administering an effective amount the composition, period time to treat disorder.
lens.org 参考文章(10)
J Milton Harris, None, Poly(ethylene glycol) chemistry : biotechnical and biomedical applications Plenum Press. ,(1992)
Kathleen Clarence-Smith, Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders ,(2005)
Robert Tridgett, Thierry Filloux, Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of symptons of huntington' s disease ,(2006)
Robert Tridgett, Robert Turtle, Ian Clarke, Grant Johnston, Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them ,(2005)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Dinesh K. Haswani, Peyman Moslemy, Avinash Nangia, Jules Jacob, Daya D. Verma, James Yeh, Ze've Shaked, Pharmaceutical compositions for treatment of parkinson's disease and related disorders ,(2007)
Roman V. Rariy, Michael Heffernan, Pharmaceutical compositions for sleep disorders ,(2005)
Boyong Li, Monte Browder, Avinash Nangia, Oral extended-release composition ,(2004)
Dinesh K. Haswani, Ze'ev Shaked, Peyman Moslemy, Avinash Nangia, Daya D. Verma, James Yeh, Jules Jacob, Dosage forms for movement disorder treatment ,(2006)
Avinash Nangia, Boyong Li, Chih Ming Chen, Xiu Xiu Cheng, Controlled release oral dosage form ,(2001)